精装
现代生物技术的经济动力学
本书以欧洲的例子来反映全球趋势，对现代生物技术的经济动态提供了一种新颖的见解。作者将理论洞察力应用于现代学习社会的基本谜团，即知识和思想的发展如何以及为什么与市场过程以及行业和公司的形成相互作用。
更多信息
Critical Acclaim
贡献者
内容
更多信息
本书以欧洲的例子来反映全球趋势，对现代生物技术的经济动态提供了一种新颖的见解。作者将理论洞察力应用于现代学习社会的基本谜团，即知识和思想的发展如何以及为什么与市场过程以及行业和公司的形成相互作用。
This book offers new empirical evidence to address such questions by studying the diversity of biotechnology in Europe. By analysing the way in which the development of new knowledge and information is linked with economic transformation, the authors are able to provide a rich theoretical understanding of the economic dynamics of knowledge within the biotechnology sector. They clearly show how innovation opportunities are affected not just by the market, but by scientific developments, networks, institutions and government policy. They also raise important theoretical questions about how and why new industries, networks and organizations are shaped, and highlight the development and impacts of biotechnology on many existing sectors, including pharmaceuticals, agriculture and insurance. The final chapter summarizes the theoretical challenges which have been overcome and identifies future areas for research.
现代生物技术的经济动态将成为学生，学者和创新，商业战略，工业组织，公司理论，技术变革经济学和区域研究的管理和经济学的研究人员的重要阅读。它还将吸引更广泛的政治和商业受众，例如政府政策制定者和生物技术公司的经理。
This book offers new empirical evidence to address such questions by studying the diversity of biotechnology in Europe. By analysing the way in which the development of new knowledge and information is linked with economic transformation, the authors are able to provide a rich theoretical understanding of the economic dynamics of knowledge within the biotechnology sector. They clearly show how innovation opportunities are affected not just by the market, but by scientific developments, networks, institutions and government policy. They also raise important theoretical questions about how and why new industries, networks and organizations are shaped, and highlight the development and impacts of biotechnology on many existing sectors, including pharmaceuticals, agriculture and insurance. The final chapter summarizes the theoretical challenges which have been overcome and identifies future areas for research.
现代生物技术的经济动态将成为学生，学者和创新，商业战略，工业组织，公司理论，技术变革经济学和区域研究的管理和经济学的研究人员的重要阅读。它还将吸引更广泛的政治和商业受众，例如政府政策制定者和生物技术公司的经理。
Critical Acclaim
‘All would agree that with more than 3,000 new firms formed in Europe, Japan and the United States focused on biotechnology, and with elegant strides forward in our understanding of genetics, the genome, proteomics and other related fields, a true intellectual, social and industrial revolution is in the making. Maureen McKelvey et al provide fascinating data on firm formation, case studies of emerging business models and cross-regional and national comparisons. The work is a useful beginning in our understanding of an emerging phenomenon.’
- 美国马萨诸塞州理工学院的James M. Utterback
‘This book is a highly ambitious work, the joint product of 25 co-authors. It represents an attempt to examine modern biotechnology as an economic process and, in so doing, it draws heavily – and successfully – upon the conceptual framework of evolutionary economics and the literature on industrial management. The empirical focus is on the present-day European scene, and it is a great virtue of the book that it unpacks and illuminates the diversity that characterizes that scene today. The wide coverage, along with the differing perspectives of individual authors, provides the reader with an invaluable platform for future research upon an industry that seems clearly destined to serve as an engine of economic growth in the new century.’
– Nathan Rosenberg, Stanford University, US
- 美国马萨诸塞州理工学院的James M. Utterback
‘This book is a highly ambitious work, the joint product of 25 co-authors. It represents an attempt to examine modern biotechnology as an economic process and, in so doing, it draws heavily – and successfully – upon the conceptual framework of evolutionary economics and the literature on industrial management. The empirical focus is on the present-day European scene, and it is a great virtue of the book that it unpacks and illuminates the diversity that characterizes that scene today. The wide coverage, along with the differing perspectives of individual authors, provides the reader with an invaluable platform for future research upon an industry that seems clearly destined to serve as an engine of economic growth in the new century.’
– Nathan Rosenberg, Stanford University, US
贡献者
贡献者：C。Autant-Bernard，J。Brink，S。Brusoni，S。Casper，R。Cutts，L。Dahlander，S。Gee，A。Geuna，M。Harvey，M.M。霍普金斯，H。Kettler，J。Laage-Hellman，R.L。Jensen，V。Mangematin，N。Massard，M。McKelvey，A。McMeekin，F。Murray，P。Nightingale，L。Orsenigo，M。Quéré，A。Rickne，A。Rickne，J。Senker，K。Smith，F。Valentin
内容
内容:
Preface
第一部分：介绍
1。Introduction
Jens Laage-Hellman, Maureen McKelvey and Annika Rickne
2.概念化和测量现代生物技术
Johan Brink, Maureen McKelvey and Keith Smith
第二部分：设置场景
3. Stylized Facts about Innovation Processes in Modern Biotechnology
Maureen McKelvey, Annika Rickne and Jens Laage-Hellman
4.生成后的时代：生命科学行业组织中的破裂？
米歇尔·奎尔（MichelQuéré）
5.欧洲生物技术创新的概述：公司，需求，政府政策和研究
杰奎琳·森克（Jacqueline Senker）
Part III: Challenging the Existing
6. Risk Management and the Commercialization of Human Genetic Testing in the UK
迈克尔·霍普金斯和保罗·夜莺
7. Network and Technology Systems in Science-driven Fields: The Case of European Food Biotechnology
Finn Valentin和Rasmus Lund Jensen
8. Future Imperfect: The Response of the Insurance Industry to the Emergence of Predictive Genetic Testing
Stefano Brusoni, Rachel Cutts and Aldo Geuna
9. Emergent Bioinformatics and Newly Distributed Innovation Processes
Andrew McMeekin, Mark Harvey and Sally Gee
第四部分：成立新的
10. The Dynamics of Regional Specialization in Modern Biotechnology: Comparing Two Regions in Sweden and Two Regions in Australia, 1977–2001
Johan Brink, Linus Dahlander and Maureen McKelvey
11.关于企业形成的空间维度
安妮卡·里克恩（Annika Rickne）
12.检查市场的想法：欧洲的生物技术集群如何？
Steven Casper and Fiona Murray
13. Creation and Growth of High-Tech SMEs: The Role of the Local Environment
Corinne Autant-Bernard，Vincent Mangematin和Nadine Massard
第五部分：结论
14.思考和前进的方式
汉娜·凯特勒（Hannah Kettler），莫琳·麦凯维（Maureen McKelvey）和路易吉·奥尔森尼戈（Luigi Orsenigo）
指数
Preface
第一部分：介绍
1。Introduction
Jens Laage-Hellman, Maureen McKelvey and Annika Rickne
2.概念化和测量现代生物技术
Johan Brink, Maureen McKelvey and Keith Smith
第二部分：设置场景
3. Stylized Facts about Innovation Processes in Modern Biotechnology
Maureen McKelvey, Annika Rickne and Jens Laage-Hellman
4.生成后的时代：生命科学行业组织中的破裂？
米歇尔·奎尔（MichelQuéré）
5.欧洲生物技术创新的概述：公司，需求，政府政策和研究
杰奎琳·森克（Jacqueline Senker）
Part III: Challenging the Existing
6. Risk Management and the Commercialization of Human Genetic Testing in the UK
迈克尔·霍普金斯和保罗·夜莺
7. Network and Technology Systems in Science-driven Fields: The Case of European Food Biotechnology
Finn Valentin和Rasmus Lund Jensen
8. Future Imperfect: The Response of the Insurance Industry to the Emergence of Predictive Genetic Testing
Stefano Brusoni, Rachel Cutts and Aldo Geuna
9. Emergent Bioinformatics and Newly Distributed Innovation Processes
Andrew McMeekin, Mark Harvey and Sally Gee
第四部分：成立新的
10. The Dynamics of Regional Specialization in Modern Biotechnology: Comparing Two Regions in Sweden and Two Regions in Australia, 1977–2001
Johan Brink, Linus Dahlander and Maureen McKelvey
11.关于企业形成的空间维度
安妮卡·里克恩（Annika Rickne）
12.检查市场的想法：欧洲的生物技术集群如何？
Steven Casper and Fiona Murray
13. Creation and Growth of High-Tech SMEs: The Role of the Local Environment
Corinne Autant-Bernard，Vincent Mangematin和Nadine Massard
第五部分：结论
14.思考和前进的方式
汉娜·凯特勒（Hannah Kettler），莫琳·麦凯维（Maureen McKelvey）和路易吉·奥尔森尼戈（Luigi Orsenigo）
指数